Matches in Wikidata for { <http://www.wikidata.org/entity/Q92277443> ?p ?o ?g. }
- Q92277443 description "2019 nî lūn-bûn" @default.
- Q92277443 description "2019年の論文" @default.
- Q92277443 description "2019年学术文章" @default.
- Q92277443 description "2019年学术文章" @default.
- Q92277443 description "2019年学术文章" @default.
- Q92277443 description "2019年学术文章" @default.
- Q92277443 description "2019年学术文章" @default.
- Q92277443 description "2019年学术文章" @default.
- Q92277443 description "2019年學術文章" @default.
- Q92277443 description "2019年學術文章" @default.
- Q92277443 description "2019年學術文章" @default.
- Q92277443 description "2019年學術文章" @default.
- Q92277443 description "2019年學術文章" @default.
- Q92277443 description "2019년 논문" @default.
- Q92277443 description "article científic" @default.
- Q92277443 description "article scientific" @default.
- Q92277443 description "article scientifique" @default.
- Q92277443 description "articol științific" @default.
- Q92277443 description "articolo scientifico" @default.
- Q92277443 description "artigo científico" @default.
- Q92277443 description "artigo científico" @default.
- Q92277443 description "artigo científico" @default.
- Q92277443 description "artikel ilmiah" @default.
- Q92277443 description "artikull shkencor" @default.
- Q92277443 description "artikulong pang-agham" @default.
- Q92277443 description "artykuł naukowy" @default.
- Q92277443 description "artículo científico publicado en 2019" @default.
- Q92277443 description "artículu científicu" @default.
- Q92277443 description "bilimsel makale" @default.
- Q92277443 description "bài báo khoa học" @default.
- Q92277443 description "naučni članak" @default.
- Q92277443 description "scienca artikolo" @default.
- Q92277443 description "scientific article published on 27 December 2019" @default.
- Q92277443 description "scientific article published on 27 December 2019" @default.
- Q92277443 description "scientific article published on 27 December 2019" @default.
- Q92277443 description "teaduslik artikkel" @default.
- Q92277443 description "tieteellinen artikkeli" @default.
- Q92277443 description "tudományos cikk" @default.
- Q92277443 description "vedecký článok" @default.
- Q92277443 description "vetenskaplig artikel" @default.
- Q92277443 description "videnskabelig artikel udgivet 27. december 2019" @default.
- Q92277443 description "vitenskapelig artikkel" @default.
- Q92277443 description "vitskapeleg artikkel" @default.
- Q92277443 description "vědecký článek" @default.
- Q92277443 description "wetenschappelijk artikel" @default.
- Q92277443 description "wissenschaftlicher Artikel" @default.
- Q92277443 description "επιστημονικό άρθρο" @default.
- Q92277443 description "мақолаи илмӣ" @default.
- Q92277443 description "наукова стаття, опублікована в грудні 2019" @default.
- Q92277443 description "научна статия" @default.
- Q92277443 description "научная статья" @default.
- Q92277443 description "научни чланак" @default.
- Q92277443 description "научни чланак" @default.
- Q92277443 description "מאמר מדעי" @default.
- Q92277443 description "مقالة علمية نشرت في 27 ديسمبر 2019" @default.
- Q92277443 description "২৭ ডিসেম্বর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q92277443 description "บทความทางวิทยาศาสตร์" @default.
- Q92277443 description "სამეცნიერო სტატია" @default.
- Q92277443 name "Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)" @default.
- Q92277443 name "Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)" @default.
- Q92277443 type Item @default.
- Q92277443 label "Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)" @default.
- Q92277443 label "Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)" @default.
- Q92277443 prefLabel "Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)" @default.
- Q92277443 prefLabel "Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)" @default.
- Q92277443 P1433 Q92277443-428ED8AD-788A-4C4A-B56B-5D890702AA01 @default.
- Q92277443 P1476 Q92277443-821AF6FB-8667-43E3-BEFF-06DCB1B4AB74 @default.
- Q92277443 P2093 Q92277443-1267EC40-9533-46D6-A42B-873EE95E2234 @default.
- Q92277443 P2093 Q92277443-3CBD70C4-2D41-4175-9D21-E6C8B931997D @default.
- Q92277443 P2093 Q92277443-5769A45D-04AF-48CC-AB12-EA8A94C21DAB @default.
- Q92277443 P2093 Q92277443-576C3E14-448F-4A71-93C1-466DF5F18CFC @default.
- Q92277443 P2093 Q92277443-5E6AB651-7CBD-4166-B17C-8C8FFDF62D65 @default.
- Q92277443 P2093 Q92277443-61DBC8C4-D769-4A1E-B328-A46E0A1509BC @default.
- Q92277443 P2093 Q92277443-718657C2-C115-4434-A724-5ABED8E7F9AF @default.
- Q92277443 P2093 Q92277443-76D5CB71-6668-4CFC-BC06-B97D0713B286 @default.
- Q92277443 P2093 Q92277443-8CE7CC47-0AF7-4A9D-AFEB-6F6ED449EC22 @default.
- Q92277443 P2093 Q92277443-A08A8B99-52B8-4AF2-A822-8FE785CE539B @default.
- Q92277443 P2093 Q92277443-A21BDA21-9E55-487A-A8BE-B086A3842F98 @default.
- Q92277443 P2093 Q92277443-BA06FE3A-DB71-4AEC-A9A2-346A10FED8EA @default.
- Q92277443 P2093 Q92277443-BB6E72DB-52EA-40A7-8409-B28BC1271B73 @default.
- Q92277443 P2093 Q92277443-CBBF4B62-4F00-47F4-B701-E7F71F5F449B @default.
- Q92277443 P2093 Q92277443-CCA8290B-3AC7-4B78-B4B3-5550779F0E69 @default.
- Q92277443 P2093 Q92277443-CE72AD25-3004-4739-96C8-938462863A2F @default.
- Q92277443 P2093 Q92277443-D422BF41-682C-47AA-9F0B-91A408E5ABA7 @default.
- Q92277443 P2093 Q92277443-D4EEBCDE-BD05-4194-8EC5-22A48273EE67 @default.
- Q92277443 P2093 Q92277443-E4FE0159-4004-438D-AA8E-B4868CA20A9B @default.
- Q92277443 P2093 Q92277443-EEA581F3-4E16-4FFF-8802-6B18DA09D289 @default.
- Q92277443 P304 Q92277443-9F0EF941-5761-4B45-B2D6-CC600B26A487 @default.
- Q92277443 P31 Q92277443-CB3471C6-1889-414A-A434-CEA4474AF66C @default.
- Q92277443 P356 Q92277443-A7A01B3D-0880-436E-9406-DED0F0FFE797 @default.
- Q92277443 P433 Q92277443-8961082C-773B-462E-BB41-428A7A579158 @default.
- Q92277443 P478 Q92277443-D5E90F22-D95E-406C-A2C4-23B23FE44A1C @default.
- Q92277443 P577 Q92277443-CB4E753D-34CA-40FF-86A5-0BF5A9E7C64B @default.
- Q92277443 P698 Q92277443-13819FCB-A389-4182-83AF-A3F1179F0000 @default.
- Q92277443 P921 Q92277443-D74DBD47-2FAD-4D9F-A27C-CB3D39ECFE1A @default.
- Q92277443 P356 JCO.19.01494 @default.
- Q92277443 P698 31880966 @default.
- Q92277443 P1433 Q400292 @default.
- Q92277443 P1476 "Randomized Phase III Study of Continuation Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: COMPASS (WJOG5610L)" @default.
- Q92277443 P2093 "Atsushi Horiike" @default.